Nectero Medical, Inc.
Clinical trials sponsored by Nectero Medical, Inc., explained in plain language.
-
Second chance: new device retreatment for bulging aorta
Disease control Recruiting nowThis study tests whether giving a second treatment with the Nectero EAST system is safe and helps slow the growth of abdominal aortic aneurysms (a bulging blood vessel in the belly). Ten adults who already had one treatment will receive another dose. Doctors will check for side e…
Phase: NA • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New One-Time procedure aims to halt aneurysm growth
Disease control Recruiting nowThis study tests a new treatment called the Nectero EAST system for people with small to medium-sized abdominal aortic aneurysms (AAA). The goal is to see if a single treatment delivered inside the blood vessel can stabilize the aneurysm and prevent it from growing or rupturing. …
Phase: PHASE2, PHASE3 • Sponsor: Nectero Medical, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC